Lupin gets USFDA nod for generic equivalent of Mylan Specialty Perforomist Inhalation Solution Ruchika Sharma24 Aug 2022 5:00 PM ISTPERFOROMIST Inhalation Solution is a long-acting beta2-adrenergic agonist (beta2-agonist)
Lupin rationalising product portfolio in US to overcome price erosion impact, says CEO Vinita Gupta Ruchika Sharma16 Aug 2022 1:30 PM ISTLupin's transitioning of the portfolio from the simple generic oral solids to complex generics had started with short-acting bronchodilator albuterol.
Short-term oxygen therapy need in COPD patients indicative of worse outcomes in acute illness: Study Medha Baranwal8 Aug 2022 5:30 PM ISTCanada: Persistent hypoxemia requiring short-term oxygen therapy (STOT) following an acute respiratory illness in COPD is a marker of disease...
Narrower airways in women increase their risk of COPD Dr. Kamal Kant Kohli3 Aug 2022 7:30 PM ISTWomen have narrower lung airways which increase their risk of chronic obstructive pulmonary disease (COPD) compared to their male...
Increased COPD risk for women due to smaller airways Isra Zaman3 Aug 2022 9:00 AM ISTStructural differences in lung airways between men and woman may be the cause of differences in chronic obstructive pulmonary disease (COPD)...
Single-inhaler triple treatment for COPD lowers exacerbation and mortality in COPD patients Jacinthlyn Sylvia17 July 2022 7:30 PM ISTIn a new study conducted by Bernardino Alcázar-Navarrete and colleagues, it was found that COPD patients who started Single-inhaler triple therapy...
Home oxygen has no benefit in patients with COPD and moderate hypoxemia: Lancet Jacinthlyn Sylvia16 July 2022 9:00 AM ISTUSA: A new study published in The Lancet Respiratory Medicine suggests that patients with chronic obstructive pulmonary disease (COPD) and mild...
Frequent productive cough signals higher risk of disease burden in asthma and COPD: Study Dr. Hiral patel5 July 2022 9:30 AM ISTUK: Frequent productive cough is a key indicator of adverse clinical outcomes across asthma and/or chronic obstructive pulmonary disease (COPD),...
2-days course of levofloxacin good enough for controlling acute exacerbations of COPD Jacinthlyn Sylvia29 Jun 2022 11:23 PM ISTTunisia: In a new study by Salma Messous and team it was found that in acute exacerbation of COPD (AECOPD), levofloxacin once daily for two days was...
Triglyceride-glucose (TyG) index, a novel risk marker of future COPD in women: Study Dr. Hiral patel28 Jun 2022 9:00 AM ISTSweden: Insulin resistance, estimated by the TyG index may precede the development of obstructive lung disease in women, states an article published...
Poor sleep tied to risk of life-threatening COPD flare-ups: Study Dr. Hiral patel24 Jun 2022 10:45 AM ISTUSA: Poor sleep quality may increase the risk of life-threatening exacerbations in people with chronic obstructive pulmonary disease (COPD), states an...
Children having bronchitis during childhood prone to have asthma and pneumonia later Dr. Kamal Kant Kohli22 Jun 2022 9:30 AM ISTAccording to research from the Allergy and Lung Health Unit at the University of Melbourne, bronchitis in early childhood has been found to increase...
